Source:http://linkedlifedata.com/resource/pubmed/id/17006939
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2006-10-3
|
pubmed:abstractText |
Hepatocyte growth factor (HGF) and beta-catenin both play a crucial role in stimulating hepatocyte proliferation, but whether these 2 pathways cooperate in inducing hepatocyte proliferation is unclear. We have previously reported that beta-catenin forms a complex with c-Met (HGF receptor) that undergoes dissociation because of beta-catenin tyrosine phosphorylation on stimulation by HGF. It is also known that delivery of the human HGF gene cloned in a plasmid under a CMV promoter results in hepatomegaly in mice. In addition, recently characterized beta-catenin transgenic mice also showed hepatomegaly. The present study was based on the hypothesis that HGF-induced hepatomegaly is mediated, at least in part, by activation of the Wnt/beta-catenin pathway. Here we report that delivery of the human HGF gene delivery in mice led to hepatomegaly via beta-catenin activation in the liver in 1- and 4-week studies. The mechanisms of beta-catenin activation in the 1-week study included loss of c-Met-beta-catenin association as well as canonical beta-catenin activation, leading to its nuclear translocation. In the 4-week study, beta-catenin activation was observed via canonical mechanisms, whereas the c-Met-beta-catenin complex remained unchanged. In both studies there was an associated increase in the E-cadherin-beta-catenin association at the membrane. In addition, we generated liver-specific beta-catenin knockout mice, which demonstrated significantly smaller livers. HGF gene delivery failed to induce hepatomegaly in these beta-catenin conditionally null mice. In conclusion, beta-catenin- and HGF-mediated signaling pathways cooperate in hepatocyte proliferation, which may be crucial in liver development, regeneration following partial hepatectomy, and pathogenesis of hepatocellular carcinoma.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0270-9139
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
44
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
992-1002
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:17006939-Animals,
pubmed-meshheading:17006939-Cadherins,
pubmed-meshheading:17006939-Gene Transfer Techniques,
pubmed-meshheading:17006939-Hepatocyte Growth Factor,
pubmed-meshheading:17006939-Hepatocytes,
pubmed-meshheading:17006939-Hepatomegaly,
pubmed-meshheading:17006939-Male,
pubmed-meshheading:17006939-Mice,
pubmed-meshheading:17006939-Mice, Inbred Strains,
pubmed-meshheading:17006939-Mice, Knockout,
pubmed-meshheading:17006939-Plasmids,
pubmed-meshheading:17006939-Promoter Regions, Genetic,
pubmed-meshheading:17006939-Protein Transport,
pubmed-meshheading:17006939-Signal Transduction,
pubmed-meshheading:17006939-Wnt Proteins,
pubmed-meshheading:17006939-beta Catenin
|
pubmed:year |
2006
|
pubmed:articleTitle |
Activation of Wnt/beta-catenin pathway during hepatocyte growth factor-induced hepatomegaly in mice.
|
pubmed:affiliation |
Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15216, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|